Novel therapeutics for type 2 diabetes: insulin resistance.
about
Anti-Diabetic Effects of Jiang Tang Xiao Ke Granule via PI3K/Akt Signalling Pathway in Type 2 Diabetes KKAy MicePharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.BioM2MetDisease: a manually curated database for associations between microRNAs, metabolites, small molecules and metabolic diseases.Autophagy and its link to type II diabetes mellitusImpact of hypothalamic reactive oxygen species in the regulation of energy metabolism and food intakeMetformin Prevents Nonunion after Three-Cannulated-Screw Fixation in Displaced Femoral Neck Fractures: A Retrospective Study.A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.Obstructive sleep apnoea and polycystic ovary syndrome: A comprehensive review of clinical interactions and underlying pathophysiology.Preoperative weight loss with glucagon-like peptide-1 receptor agonist treatment predicts greater weight loss achieved by the combination of medical weight management and bariatric surgery in patients with type 2 diabetes: A longitudinal analysis.Evaluation of 4-methyl-2-[(2-methylbenzyl) amino]-1,3-thiazole-5-carboxylic acid against hyperglycemia, insulin sensitivity, and oxidative stress-induced inflammatory responses and β-cell damage in the pancreas of streptozotocin-induced diabetic ratAntidiabetic Effects of a Chinese Herbal Medicinal Compound Sangguayin Preparation via PI3K/Akt Signaling Pathway in db/db Mice.Non-pharmacological Treatment Options in the Management of Diabetes Mellitus
P2860
Q28468437-39003774-528D-4A88-9CA1-8B8ED1A7BD2EQ30249371-A49356F3-E7D4-47F2-B57A-16AA394DE8AFQ33787528-B5987F15-7BB5-4607-9A41-793E53FC29E2Q33821526-501F8D72-B1A1-417F-8F95-44DFB27894DCQ35114807-72E98867-7286-401A-B813-6B73634102DCQ37470824-B2AC3339-F53F-4B2C-8924-B3E302B2A1EDQ38293103-087935BD-23A9-43FF-9C4A-CF5D2D8ACD41Q39391344-162E132D-4C2D-4368-A927-9659CFD3C50DQ47180841-27CF95D7-7D46-446E-9392-36CD1C5DE4CBQ47786382-DFEC8149-1FC3-4E65-B9CE-504192CB5121Q54114678-14E72286-9E06-4A43-ADA1-2B70EE0CBB7CQ57822734-5DF203E2-AF3C-448E-832A-61E1AD8E0B8C
P2860
Novel therapeutics for type 2 diabetes: insulin resistance.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Novel therapeutics for type 2 diabetes: insulin resistance.
@en
type
label
Novel therapeutics for type 2 diabetes: insulin resistance.
@en
prefLabel
Novel therapeutics for type 2 diabetes: insulin resistance.
@en
P2860
P356
P1476
Novel therapeutics for type 2 diabetes: insulin resistance.
@en
P2093
A H Barnett
P2860
P304
P356
10.1111/DOM.12400
P577
2014-11-12T00:00:00Z